Larvol Delta - BioPath-Holdings-Announces-Clearance-of-Investigational-New-Drug-Application-for-BP1002-in-RefractoryRelapsed-Acute-Myeloid-Leukemia-Patients

liposomal Bcl2 (BP1002) - Bio-Path

https://www.globenewswire.com/news-release/2021/08/24/2285391/0/en/Bio-Path-Holdings-Announces-Clearance-of-Investigational-New-Drug-Application-for-BP1002-in-Refractory-Relapsed-Acute-Myeloid-Leukemia-Patients.html

Aug 24, 2021

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next